Back to search

Article

Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response

2024-11-06

Abstract excerpt

The advent of tyrosine kinase inhibitors (TKIs) as treatment of chronic myeloid leukemia (CML) is a paradigm in molecularly targeted cancer therapy. Nonetheless, TKI-insensitive leukemia stem cells (LSCs) persist in most patients even after years of treatment and are imperative for disease progression as well as recurrence during treatment-free remission (TFR). Here, we have generated high-resolution single-cell m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
42b0ffd3-a843-57eb-9b04-9925a1d9c83d
DOI
10.7554/elife.92074.3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy responseDOI 10.7554/elife.92074.3
Select a neighboring publication to make it the new centre.